10 citations
,
June 2010 in “Fertility and Sterility” In this study, patients with polycystic ovary syndrome self-reported higher hirsutism scores compared to clinician assessments, but only clinician scores correlated with biochemical markers of hyperandrogenism.
24 citations
,
January 2017 in “Journal of Cutaneous and Aesthetic Surgery” In this pilot study, botulinum toxin was found to be a safe and effective treatment for androgenetic alopecia in most participants, though larger studies are needed to confirm these findings.
This review highlights the emerging role of nursing in hair and scalp health, emphasizing the importance of integrating nutrition education into nursing practice to enhance patient outcomes, self-esteem, and holistic care, despite current gaps in nursing curricula and care protocols.
52 citations
,
March 2016 in “JAMA dermatology” This study found that hirsutism significantly negatively impacts quality of life, with self-assessed severity more strongly linked to quality-of-life impact and depressive symptoms than clinician assessments.
6 citations
,
June 2018 in “PLOS ONE” This study demonstrated that the Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata cases with high sensitivity and specificity in a dermatology clinic setting.
April 2026 in “Research Square” This study found that dental students' manual dexterity was weakly associated with their performance in skills-based assessments, while self-perceived skill levels showed no significant correlation with assessment outcomes, suggesting a potential benefit from focusing on dexterity enhancement in dental education.
This review explores the risk factors, associated comorbidities, and psychological impacts of early-onset androgenetic alopecia, highlighting its complexity and potential implications for treatment response and overall health.
January 2019 in “OpenBU/Boston University Institutional Repository (Boston University)” In this study, women with a PCOS diagnosis were more likely to report clinical signs of androgen excess, including hirsutism, acne, and alopecia, with ethnic patterns in symptom prevalence.
39 citations
,
November 2017 in “Journal of The American Academy of Dermatology” This review presents standardized methods for assessing and tracking hair loss in alopecia areata but reports no clinical results, with the authors noting time limitations in clinical practice.
39 citations
,
March 2007 in “Journal of Cosmetic Dermatology” This study in identical twin males with androgenetic alopecia found that dutasteride significantly improved hair growth compared to placebo over one year.
32 citations
,
December 2004 in “BMC Public Health” This study found that trained observers using the Hamilton-Norwood classification were very reliable in assessing balding patterns, while men's self-assessments were moderately accurate compared to observers.
February 2026 in “Applied Health Economics and Health Policy” This study highlights the limited number of cross-sectoral evaluations of health interventions and suggests that guidance from health technology assessment agencies could enhance evidence and encourage novel investment in population health.
February 2026 in “BMJ Open” In this assessment of existing research on DTC commercial virtual care, it is highlighted that impacts on care quality, health outcomes, system use, and privacy ethics remain unclear, with potential bias noted due to industry financial connections.
2 citations
,
April 2021 in “Journal of Cosmetic Dermatology” This study found that androgenetic alopecia significantly impacts young men's quality of life, affecting their self-esteem and daily functioning, and highlights the need for a specialized assessment tool.
11 citations
,
February 2011 in “Current Zoology” The researchers reported that alopecia is common in Japanese macaques, particularly adult females, and varies seasonally and between different populations, with a new scoring system proposed for monitoring.
5 citations
,
June 2016 in “TURKDERM” This review discusses various dermatological scoring systems used to objectively assess disease severity and guide treatment decisions, reporting no new clinical results.
1 citations
,
January 2024 in “Archives of Endocrinology and Metabolism” This study found that self-assessed mFG and Hirsuta scores have low specificity for diagnosing hirsutism in clinical settings, though they may still be useful for screening in epidemiological studies.
12 citations
,
June 2024 in “Archives of Dermatological Research” This scoping review found a high prevalence of skin conditions among older people living at home, but available evidence on burden and effective care strategies is limited.
1 citations
,
December 2022 in “JAMA Dermatology” This study found that the HairComb algorithm achieved high accuracy in quantifying percentage hair loss across various types of alopecia, suggesting its potential for standardized automated assessments.
June 2025 in “British Journal of Dermatology” This study introduces ALUDWIG, an automated tool for assessing female androgenic alopecia severity from smartphone images, which may offer a more consistent alternative to current scoring methods like the Ludwig scale.
February 2024 in “International neuropsychiatric disease journal” In this abstract, the authors provide an overview of the psychological impact of alopecia areata, highlighting how this autoimmune disorder can lead to reduced quality of life, increased anxiety and depression symptoms, and decreased work productivity due to hair loss and its social implications.
18 citations
,
October 2015 in “Journal of the European Academy of Dermatology and Venereology” This assessment of European Dermatology Forum guidelines found varying methodological quality, with S3 guidelines scoring highest overall, highlighting a need for standardization in guideline development.
1 citations
,
March 2025 in “Acta fytotechnica et zootechnica/Acta fytotechnica et zootechnica” This study evaluated quercetin's potential as a treatment for cats with Feline Atopic Skin Syndrome, finding it significantly reduced clinical scores in certain symptom groups like Head-and-Neck Pruritus and Miliary Dermatitis, although improvements in oxidative stress markers were not clearly significant.
January 2026 in “Open Science Framework” This scoping review describes the current use of artificial intelligence in alopecia research, highlighting AI's evolution from diagnostic to prognostic applications in dermatology and identifying gaps in multimodal integration and fairness across demographics.
3 citations
,
December 2020 in “Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego” In this study, female patients with androgenetic alopecia reported high stress levels, but the type of hair loss treatment did not significantly affect stress alleviation.
November 2024 in “Journal of Cosmetic Dermatology” This study evaluated eyebrow mesotherapy with a growth factor-based cocktail in 32 women with thin eyebrows, finding high satisfaction rates (90.6%) with significant improvements in density and appearance, low pain levels, and unanimous willingness to recommend the treatment.
January 2009 in “Springer eBooks” The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.
July 2026 in “Deviant Behavior” This scoping review examined biopsychosocial markers associated with identifying as an involuntary celibate (incel), highlighting physical appearance perceptions, mental health challenges, and social victimization experiences, and suggesting tailored prevention strategies.
7 citations
,
February 2023 in “Journal of Dermatological Treatment” This study concluded that the Scalp Photographic Index is a reliable and validated tool for objectively classifying and scoring various scalp conditions.
March 2026 in “Applied Sciences” In this scoping review, researchers observed that while AI-assisted trichoscopy holds promise for standardized assessments of hair and scalp disorders, its clinical translation is limited by small proprietary datasets, inconsistent validation protocols, and a scarcity of real-world clinical studies.